The impact of motor and non motor symptoms on health state values in newly diagnosed idiopathic Parkinson's disease

Journal of Neurology

Volumn 259, Issue 3, 2012, Pages 462-468

  Shearer, James ^a   Green, Colin ^a   Counsell, Carl E ^b   Zajicek, John P ^c  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

Author keywords

EQ 5D; Non motor symptoms; Parkinson's disease; Predictors; Quality of life

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT;

ADULT; AGED; ARTICLE; DEPRESSION; FEMALE; HEALTH STATUS; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; PAIN; PARKINSON DISEASE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; SELF REPORT; SYMPTOM;

ADULT; AGED; AGED, 80 AND OVER; DEPRESSION; FEMALE; HEALTH STATUS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOVEMENT; PAIN; PARKINSON DISEASE; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS;

EID: 84861584760     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-011-6202-y     Document Type: Article

References (34)

1. Wickremaratchi MM, Perera D, O'Loghlen C et al (2009) Prevalence and age of onset of Parkinson's disease in Cardiff: a community based cross sectional study and meta-analysis. J Neurol Neurosurg Psychiatry 80:805-807
2. de Lau L, Breteler M (2006) Epidemiology of Parkinson's disease. Lancet Neurol 5:525-535 (Pubitemid 44262284)
3. Dowding C, Shenton C, Salek S (2006) A review of the healthrelated quality of life and economic impact of Parkinson's disease. Drugs Aging 23:693-721 (Pubitemid 44536905)
4. Rascol O, Payoux P, Ory F et al (2003) Limitations of current Parkinson's disease therapy. Ann Neurol 53:S3-S12
5. Soh S-E, Morris M, McGinley J (2011) Determinants of healthrelated quality of life in Parkinson's disease. Parkinsonism Relat Disord 17:1-9
6. Gallagher D, Lees A, Schrag A (2010) What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them? Mov Disord 25:2493-2500
7. Canadian Agency for Drugs and Technologies in Health (2006) Canadian Agency for Drugs and Technologies in Health, Ottawa
8. National Institute for Health and Clinical Excellence (2008) Guide to the methods of technology appraisal. National Institute for Health and Clinical Excellence, London
9. Pharmaceutical Benefits Advisory Committee. Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee. Barton: Australian Government Department of Health and Ageing; 2008
10. Dorsey E, Meltzer D (2010) The economics of comparative effectiveness research. Neurology 75:492-493
11. Caslake R, Moore J, Gordon J et al (2008) Changes in diagnosis with follow-up in an incident cohort of patients with Parkinsonism. J Neurol Neurosurg Psychiatry 79:1202-1207
12. Taylor K, Counsell C, Harris C et al (2006) Pilot study of the incidence and prognosis of degenerative Parkisonian disorders in Aberdeen, United Kingdom: methods and preliminary results. Mov Disord 21:976-982 (Pubitemid 44184599)
13. Fahn S, Elton R (1987) UPDRS Development Committee. The Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden C, Goldstein M, Calne D (eds) Recent developments in Parkinson's disease. vol 2. Macmillan Healtcare Information, Florham Park, NJ, 153-163
14. Goetz C, Poewe W, Rascol O et al (2004) Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease. Mov Disord 19:1020-1028 (Pubitemid 39302834)
15. Folstein M, Folstein S, McHugh P (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
16. Mahieux F, Michelet D, Manifacier M-E et al (1995) Mini-mental Parkinson: First validation of a new bedside test constructed for Parkinson's disease. Behav Neurol 8:15-22
17. Weintraub D, Oehlberg K, Katz I et al (2006) Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease. Am J Geriatr Psychiatry 14:169-175 (Pubitemid 43227640)
18. Wade D, Collin C (1988) The Barthel ADL Index: A standard measure of physical disability? Int Disabil Stud. 10:64-67
19. Brooks R, Group TE (1996) EuroQol: the current state of play. Health Policy 37:53-72 (Pubitemid 26191458)
20. Schrag A, Selai C, Jahanshahi M et al (2000) The EQ-5D-a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 69:67-73 (Pubitemid 30410417)
21. Dolan P (1997) Modeling Valuations for EuroQol Health States. Med Care 35:1095-1108 (Pubitemid 127453463)
22. Schrag A, Jahanshahi M, Quinn N (2000) How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Mov Disord 15:1112-1118
23. Siderowf A, Ravina B, Glick H (2002) Preference-based qualityof-life in patients with Parkinson's disease. Neurology 59:103-108 (Pubitemid 34742802)
24. Reuther M, Spottke E, Klotsche J et al (2007) Assessing healthrelated quality of life in patients with Parkinson's disease in a prospective longitudinal study. Parkinsonism Relat Disord 13:108-114 (Pubitemid 46329519)
25. Vossius C, Nilsen OB, Larsen JP (2009) Health state values during the first year of drug treatment in early-stage Parkinson's disease: a prospective, population-based, cohort study. Drugs Aging 26:973-980
26. Rahman S, Griffin H, Quinn N et al (2008) Quality of life in Parkinson's disease: the relative importance of the symptoms. Mov Disord 23:1428-1434
27. Roh JH, Kim BJ, Jang JH et al (2009) The relationship of pain and health-related quality of life in Korean patients with Parkinson's disease. Acta Neurol Scand 119:397-403
28. Lee M, Walker R, Hildreth T et al (2006) A survey of pain in idiopathic Parkinson's disease. J Pain Symptom Manag 32:462-469 (Pubitemid 44666294)
29. Beiske AG, Loge JH, Ronningen A et al (2009) Pain in Parkinson's disease: Prevalence and characteristics. Pain Jan 141:173-177
30. Forsaa E, Larsen J, Wentzel-Larsen T et al (2008) Predictors and course of health-related quality of life in Parkinson's disease. Mov Disord 23:1420-1427
31. Qin Z, Zhang L, Sun F et al (2009) Health related quality of life in early Parkinson's disease: impact of motor and non-motor symptoms, results from Chinese levodopa exposed cohort. Parkinsonism Relat Disord 15:767-771
32. Li H, Zhang M, Chen L et al (2010) Nonmotor symptoms are independently associated with impaired health-related quality of life in Chinese patients with Parkinson's disease. Mov Disord 25:2740-2746
33. Schrag A (2006) Quality of life and depression in Parkinson's disease. J Neurol Sci 248:151-157 (Pubitemid 44647306)
34. Chaudhuri KR, Martinez-Martin P, Brown RG et al (2007) The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study. Mov Disord 22:1901-1911 (Pubitemid 350134203)